Changing the Conversation on Adult Influenza Vaccination: England
Annual vaccination against influenza is well established in the United Kingdom. The traditional vaccination strategy has been to target groups at higher risk of infection and serious complications such as adults and children with underlying chronic medical conditions, pregnant women, and older people.
A sophisticated national campaign is shaped and driven by the public health authorities aimed to improve uptake rates of influenza vaccination. The strategy which is developed and published as part of the annual Flu Plan sets out a coordinated and multi-channel approach to guiding the implementation of an awareness campaign and providing partner organizations with information and resources ahead of the flu season.
The campaign comprises a variety of online and offline communications to ensure that key messages are transmitted effectively to a broad audience. A set of communication tools is shared by the government to maximize the coverage of the messages in the targeted audience, including an up-to-date website, factsheet, poster, video, postcard, and social media banners.
Several patient associations and organisations that represent at-risk populations including the British Lung Foundation, British Heart Foundation, Diabetes UK and Age UK actively support and participate in the campaign and create customized campaign resources and messages.
Campaign Overview: England Report
View the report providing an overview of
the adult influenza campaign in England.
England Resources

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.